Literature DB >> 28285700

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.

Georgiana Bentea1, Claudine Sculier1, Bogdan Grigoriu1, Anne-Pascale Meert2, Valérie Durieux3, Thierry Berghmans2, Jean-Paul Sculier4.   

Abstract

The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the third of a series of five and deals mainly with neurological paraneoplastic syndromes involving the central nervous system.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28285700     DOI: 10.1016/j.lungcan.2017.01.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

Review 1.  Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders.

Authors:  Michelle Coureau; Anne-Pascale Meert; Thierry Berghmans; Bogdan Grigoriu
Journal:  Front Med (Lausanne)       Date:  2020-05-07

2.  Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer.

Authors:  Vinicius Ernani; Lin Du; Helen J Ross; Joanne E Yi; Jason A Wampfler; Steven E Schild; Hao Xie; Karen L Swanson; Henry D Tazelaar; Ping Yang
Journal:  Thorac Cancer       Date:  2022-02-23       Impact factor: 3.500

3.  Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.

Authors:  Sizhu Gong; Yue Han; Enling He; Min Liu; Xiyao Fu; Fang Deng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

4.  Prognostic Factors in Anti-Neuronal Antibody Positive Patients.

Authors:  Çağla Aydin; Şenay Yıldız Çelik; Sema İçöz; Canan Ulusoy; Tuncay Gündüz; Gülşen Akman Demir; Murat Kürtüncü; Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

5.  A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer.

Authors:  Jennifer L Nichols; Brett J Lee; Kathryn A Chung
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-06-16

6.  Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.

Authors:  Lan Wang; Haiyan Lou; Bo Li; Jun Li; Yun-Mei Yang
Journal:  Invest New Drugs       Date:  2021-07-21       Impact factor: 3.850

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.